Home » Topics » Regulatory

Regulatory
RSS

FDA approves Novartis's panobinostat for multiple myeloma

Feb. 24, 2015

FDA approves Dymista for use in children with seasonal allergic rhinitis

Feb. 24, 2015

First stem cell-based medicinal product approved in Europe

Feb. 23, 2015

FDA approves sNDA for rufinamide in Lennox-Gastaut syndrome in children aged 1-4 years

Feb. 16, 2015

FDA approves lenvatinib for thyroid cancer

Feb. 16, 2015

CrystalGenomics' polmacoxib approved in South Korea for osteoarthritis

Feb. 9, 2015

FDA grants accelerated approval for Ibrance in advanced breast cancer

Feb. 4, 2015

FDA approves Glyxambi for type 2 diabetes

Feb. 3, 2015

FDA approves first drug for Waldenstrom's macroglobulinemia

Feb. 2, 2015

FDA approves Vyvanse for binge eating disorder

Feb. 2, 2015